Swiss vaccine developer AmVac AG is teaming up with Bayer AG subsidiary Icon Genetics GmbH to develop a plant-based production system for making an adjuvanted influenza vaccine. (BioWorld International)

LONDON - Astex Therapeutics Ltd. sealed a deal worth a potential $500 million, licensing its fibroblast growth factor receptor (FGFR) inhibitor and agreeing on a drug discovery program around two cancer targets, with Janssen Pharmaceutica NV. (BioWorld International)